Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis

INTRODUCTION: The combination of hydralazine–isosorbide dinitrate (H-ISDN) has potential as a heart failure (HF) therapy in the setting of maintenance dialysis. METHODS: In this retrospective study, we analyzed the efficacy of H-ISDN using United States Renal Data System (USRDS) data. We identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavrakanas, Thomas A., Soomro, Qandeel H., Charytan, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171697/
https://www.ncbi.nlm.nih.gov/pubmed/35685328
http://dx.doi.org/10.1016/j.ekir.2022.03.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171697/
https://www.ncbi.nlm.nih.gov/pubmed/35685328
http://dx.doi.org/10.1016/j.ekir.2022.03.032

Ejemplares similares